

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.38778991 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.38778991 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.89557016 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.84560097 |
| 5 | ribosomal small subunit assembly (GO:0000028) | 4.83323288 |
| 6 | negative regulation of cell killing (GO:0031342) | 4.66548306 |
| 7 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.66548306 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.62362348 |
| 9 | DNA deamination (GO:0045006) | 4.48203609 |
| 10 | viral transcription (GO:0019083) | 4.41898868 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.39986592 |
| 12 | translational termination (GO:0006415) | 4.22351686 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 4.12950792 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 4.12950792 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.12950792 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.12950792 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.12950792 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 4.12950792 |
| 19 | response to peptidoglycan (GO:0032494) | 4.02542130 |
| 20 | negative regulation of phagocytosis (GO:0050765) | 3.97452082 |
| 21 | positive regulation of B cell differentiation (GO:0045579) | 3.89809853 |
| 22 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.87114853 |
| 23 | detection of bacterium (GO:0016045) | 3.80555415 |
| 24 | translational elongation (GO:0006414) | 3.79267639 |
| 25 | detection of other organism (GO:0098543) | 3.77941769 |
| 26 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.76186476 |
| 27 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.67442393 |
| 28 | macrophage activation involved in immune response (GO:0002281) | 3.67054283 |
| 29 | protein targeting to ER (GO:0045047) | 3.63209963 |
| 30 | cotranslational protein targeting to membrane (GO:0006613) | 3.61138894 |
| 31 | regulation of gamma-delta T cell activation (GO:0046643) | 3.60200140 |
| 32 | regulation of mast cell degranulation (GO:0043304) | 3.52894334 |
| 33 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.45103485 |
| 34 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.42112969 |
| 35 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.42084915 |
| 36 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.38479686 |
| 37 | protein localization to endoplasmic reticulum (GO:0070972) | 3.37344260 |
| 38 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.35270308 |
| 39 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.32766164 |
| 40 | DNA unwinding involved in DNA replication (GO:0006268) | 3.32053296 |
| 41 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.30605171 |
| 42 | granulocyte activation (GO:0036230) | 3.28737870 |
| 43 | regulation of B cell differentiation (GO:0045577) | 3.28664670 |
| 44 | viral life cycle (GO:0019058) | 3.27811945 |
| 45 | DNA strand elongation (GO:0022616) | 3.24524122 |
| 46 | neutrophil activation (GO:0042119) | 3.23441123 |
| 47 | translational initiation (GO:0006413) | 3.21541008 |
| 48 | myeloid cell activation involved in immune response (GO:0002275) | 3.20656588 |
| 49 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.18375276 |
| 50 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.17926916 |
| 51 | immunoglobulin mediated immune response (GO:0016064) | 3.17738446 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 3.17524618 |
| 53 | maturation of SSU-rRNA (GO:0030490) | 3.16063038 |
| 54 | detection of external biotic stimulus (GO:0098581) | 3.14511542 |
| 55 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14368058 |
| 56 | cellular protein complex disassembly (GO:0043624) | 3.14273548 |
| 57 | regulation of antigen processing and presentation (GO:0002577) | 3.08086112 |
| 58 | cellular response to type I interferon (GO:0071357) | 3.07781314 |
| 59 | type I interferon signaling pathway (GO:0060337) | 3.07781314 |
| 60 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.06110079 |
| 61 | response to type I interferon (GO:0034340) | 3.05264986 |
| 62 | NIK/NF-kappaB signaling (GO:0038061) | 3.05015282 |
| 63 | regulation of leukocyte degranulation (GO:0043300) | 3.04924997 |
| 64 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.00638192 |
| 65 | mannose metabolic process (GO:0006013) | 3.00504560 |
| 66 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.00207664 |
| 67 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.97190645 |
| 68 | positive regulation of antigen processing and presentation (GO:0002579) | 2.96636097 |
| 69 | respiratory burst (GO:0045730) | 2.95549544 |
| 70 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.93290198 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 2.92365589 |
| 72 | protein complex disassembly (GO:0043241) | 2.91790870 |
| 73 | leukocyte aggregation (GO:0070486) | 2.90986033 |
| 74 | IMP biosynthetic process (GO:0006188) | 2.89972663 |
| 75 | DNA replication initiation (GO:0006270) | 2.89064983 |
| 76 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.87865322 |
| 77 | cellular extravasation (GO:0045123) | 2.87121524 |
| 78 | amino sugar catabolic process (GO:0046348) | 2.84406134 |
| 79 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.83511488 |
| 80 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.82593883 |
| 81 | leukocyte degranulation (GO:0043299) | 2.82381001 |
| 82 | regulation of mast cell activation (GO:0033003) | 2.81392305 |
| 83 | B cell mediated immunity (GO:0019724) | 2.80498195 |
| 84 | response to host immune response (GO:0052572) | 2.80200118 |
| 85 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80200118 |
| 86 | response to muramyl dipeptide (GO:0032495) | 2.80175561 |
| 87 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.80018779 |
| 88 | positive regulation of mast cell activation (GO:0033005) | 2.79852263 |
| 89 | negative thymic T cell selection (GO:0045060) | 2.79264120 |
| 90 | telomere maintenance via recombination (GO:0000722) | 2.75845092 |
| 91 | negative regulation of granulocyte differentiation (GO:0030853) | 2.75146572 |
| 92 | negative regulation of innate immune response (GO:0045824) | 2.73775235 |
| 93 | pentose-phosphate shunt (GO:0006098) | 2.72852189 |
| 94 | negative T cell selection (GO:0043383) | 2.71903893 |
| 95 | megakaryocyte development (GO:0035855) | 2.71096329 |
| 96 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70585894 |
| 97 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.70298098 |
| 98 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.70165604 |
| 99 | detection of biotic stimulus (GO:0009595) | 2.69228151 |
| 100 | tolerance induction (GO:0002507) | 2.68996409 |
| 101 | cellular response to zinc ion (GO:0071294) | 2.68322210 |
| 102 | macromolecular complex disassembly (GO:0032984) | 2.67505542 |
| 103 | regulation of T cell tolerance induction (GO:0002664) | 2.67048466 |
| 104 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.66273887 |
| 105 | T cell apoptotic process (GO:0070231) | 2.66127515 |
| 106 | IMP metabolic process (GO:0046040) | 2.65976733 |
| 107 | regulation of platelet aggregation (GO:0090330) | 2.65091603 |
| 108 | regulation of erythrocyte differentiation (GO:0045646) | 2.63990109 |
| 109 | detection of molecule of bacterial origin (GO:0032490) | 2.63827159 |
| 110 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.63385376 |
| 111 | germinal center formation (GO:0002467) | 2.63149676 |
| 112 | pinocytosis (GO:0006907) | 2.62865801 |
| 113 | negative regulation of RNA splicing (GO:0033119) | 2.61371062 |
| 114 | positive regulation of mast cell degranulation (GO:0043306) | 2.61057013 |
| 115 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.61057013 |
| 116 | T cell selection (GO:0045058) | 2.61004607 |
| 117 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.58900645 |
| 118 | mRNA catabolic process (GO:0006402) | 2.58805665 |
| 119 | thymic T cell selection (GO:0045061) | 2.58648402 |
| 120 | defense response to protozoan (GO:0042832) | 2.58524337 |
| 121 | macrophage activation (GO:0042116) | 2.58046682 |
| 122 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.57493510 |
| 123 | negative regulation of interleukin-6 production (GO:0032715) | 2.57002061 |
| 124 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.56234693 |
| 125 | myeloid dendritic cell differentiation (GO:0043011) | 2.55550695 |
| 126 | T cell homeostasis (GO:0043029) | 2.55429983 |
| 127 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.55420946 |
| 128 | modulation by virus of host process (GO:0019054) | 2.54355772 |
| 129 | ncRNA 3-end processing (GO:0043628) | 2.53655206 |
| 130 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.53608564 |
| 131 | response to host (GO:0075136) | 2.53258243 |
| 132 | response to host defenses (GO:0052200) | 2.53258243 |
| 133 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.53258243 |
| 134 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.52872974 |
| 135 | positive regulation of granulocyte differentiation (GO:0030854) | 2.52634490 |
| 136 | telomere maintenance via telomere lengthening (GO:0010833) | 2.52408180 |
| 137 | RNA catabolic process (GO:0006401) | 2.52163815 |
| 138 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.51879002 |
| 139 | response to protozoan (GO:0001562) | 2.51574548 |
| 140 | microglial cell activation (GO:0001774) | 2.51121637 |
| 141 | oxygen transport (GO:0015671) | 2.50223986 |
| 142 | mitotic recombination (GO:0006312) | 2.46754459 |
| 143 | formation of translation preinitiation complex (GO:0001731) | 2.46016936 |
| 144 | positive thymic T cell selection (GO:0045059) | 2.44450709 |
| 145 | mature B cell differentiation involved in immune response (GO:0002313) | 2.44450114 |
| 146 | neutrophil mediated immunity (GO:0002446) | 2.44243662 |
| 147 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.43861308 |
| 148 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.43114061 |
| 149 | negative regulation of interleukin-12 production (GO:0032695) | 2.42765861 |
| 150 | definitive hemopoiesis (GO:0060216) | 2.40976821 |
| 151 | lipopolysaccharide metabolic process (GO:0008653) | 2.39562015 |
| 152 | protein targeting to membrane (GO:0006612) | 2.39201415 |
| 153 | endosome to pigment granule transport (GO:0043485) | 2.38742914 |
| 154 | endosome to melanosome transport (GO:0035646) | 2.38742914 |
| 155 | mature B cell differentiation (GO:0002335) | 2.38565649 |
| 156 | mast cell activation (GO:0045576) | 2.38564967 |
| 157 | translesion synthesis (GO:0019985) | 2.38326131 |
| 158 | response to interferon-beta (GO:0035456) | 2.38008495 |
| 159 | ribosomal large subunit biogenesis (GO:0042273) | 2.37923631 |
| 160 | myeloid dendritic cell activation (GO:0001773) | 2.37814565 |
| 161 | protein localization to kinetochore (GO:0034501) | 2.36831188 |
| 162 | T cell migration (GO:0072678) | 2.36236997 |
| 163 | lymphocyte apoptotic process (GO:0070227) | 2.35296754 |
| 164 | necroptotic process (GO:0070266) | 2.34591265 |
| 165 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.34316279 |
| 166 | regulation of necroptotic process (GO:0060544) | 2.33437929 |
| 167 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.32032468 |
| 168 | actin nucleation (GO:0045010) | 2.30388125 |
| 169 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.29766012 |
| 170 | mitotic nuclear envelope disassembly (GO:0007077) | 2.28695163 |
| 171 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.27784476 |
| 172 | regulation of protein heterodimerization activity (GO:0043497) | 2.27448483 |
| 173 | lymphocyte homeostasis (GO:0002260) | 2.26115306 |
| 174 | dosage compensation (GO:0007549) | 2.25505501 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.93748663 |
| 2 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.27550871 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.22968423 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 3.21944136 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.03784027 |
| 6 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.83697621 |
| 7 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.74846648 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.67610579 |
| 9 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.66434434 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.53170696 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.51439355 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.20439844 |
| 13 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.19667550 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.19228514 |
| 15 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18547301 |
| 16 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.17908319 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.09585761 |
| 18 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.07542228 |
| 19 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.05559768 |
| 20 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.03268514 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.01299262 |
| 22 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98053811 |
| 23 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.96092888 |
| 24 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.93882279 |
| 25 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.86365751 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.85939435 |
| 27 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.85423871 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.85345595 |
| 29 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.84868007 |
| 30 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.83689937 |
| 31 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.79427461 |
| 32 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78508731 |
| 33 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.77047039 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 1.75125295 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71275543 |
| 36 | MYB_26560356_Chip-Seq_TH2_Human | 1.71032611 |
| 37 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.70846792 |
| 38 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.67984994 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66695088 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.66680318 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.64033552 |
| 42 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.63954421 |
| 43 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.63596993 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.62038250 |
| 45 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.61274950 |
| 46 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.59675613 |
| 47 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.59349059 |
| 48 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.59109226 |
| 49 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.57762237 |
| 50 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.57544693 |
| 51 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.57328043 |
| 52 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.55346530 |
| 53 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.54125219 |
| 54 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.53580894 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.49286849 |
| 56 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.48626373 |
| 57 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.47949392 |
| 58 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.47358006 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.44896810 |
| 60 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.44666348 |
| 61 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.44380538 |
| 62 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.44365128 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.43629118 |
| 64 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.42828148 |
| 65 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42739256 |
| 66 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.42506742 |
| 67 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.41973486 |
| 68 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.40453175 |
| 69 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.40392350 |
| 70 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.38498929 |
| 71 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.35487166 |
| 72 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.33812068 |
| 73 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.33442259 |
| 74 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.32004470 |
| 75 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.31956892 |
| 76 | MAF_26560356_Chip-Seq_TH2_Human | 1.31946979 |
| 77 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.30781107 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.30616111 |
| 79 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.30148872 |
| 80 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.30016194 |
| 81 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.29533966 |
| 82 | * ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.29460470 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.29174082 |
| 84 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.29036754 |
| 85 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.28920988 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28421605 |
| 87 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.28058534 |
| 88 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.26520290 |
| 89 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.26473171 |
| 90 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.26411178 |
| 91 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.26325772 |
| 92 | SPI1_23127762_ChIP-Seq_K562_Human | 1.22541824 |
| 93 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.22187356 |
| 94 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.21844866 |
| 95 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.21712435 |
| 96 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20208393 |
| 97 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.17934311 |
| 98 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16404177 |
| 99 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.16319095 |
| 100 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.16259795 |
| 101 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.15160386 |
| 102 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.14936376 |
| 103 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.14647547 |
| 104 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14582569 |
| 105 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.13710553 |
| 106 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13057487 |
| 107 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.13039245 |
| 108 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.11725844 |
| 109 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10868590 |
| 110 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 1.10210287 |
| 111 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08433471 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08082167 |
| 113 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.07998289 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07745262 |
| 115 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.07523165 |
| 116 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07332632 |
| 117 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06471323 |
| 118 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.06003570 |
| 119 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.04698099 |
| 120 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.02329856 |
| 121 | * P68_20966046_ChIP-Seq_HELA_Human | 1.01917105 |
| 122 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01584659 |
| 123 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01367461 |
| 124 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.01238296 |
| 125 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.00890433 |
| 126 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.97677841 |
| 127 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97487681 |
| 128 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.96557097 |
| 129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.95509610 |
| 130 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.94731865 |
| 131 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.93991936 |
| 132 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92747669 |
| 133 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 0.92241730 |
| 134 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91759174 |
| 135 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.91759080 |
| 136 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.90249736 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.65062626 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.27637591 |
| 3 | MP0000685_abnormal_immune_system | 3.18228345 |
| 4 | MP0003763_abnormal_thymus_physiology | 2.52250939 |
| 5 | MP0003693_abnormal_embryo_hatching | 2.51470006 |
| 6 | MP0004808_abnormal_hematopoietic_stem | 2.49259324 |
| 7 | MP0001800_abnormal_humoral_immune | 2.46397527 |
| 8 | MP0005671_abnormal_response_to | 2.43167470 |
| 9 | * MP0002398_abnormal_bone_marrow | 2.34795985 |
| 10 | MP0003436_decreased_susceptibility_to | 2.27021883 |
| 11 | MP0009785_altered_susceptibility_to | 2.24104363 |
| 12 | * MP0002452_abnormal_antigen_presenting | 2.21827931 |
| 13 | MP0001873_stomach_inflammation | 2.21256329 |
| 14 | MP0001545_abnormal_hematopoietic_system | 2.16851442 |
| 15 | MP0005397_hematopoietic_system_phenotyp | 2.16851442 |
| 16 | * MP0002420_abnormal_adaptive_immunity | 2.16787464 |
| 17 | * MP0005464_abnormal_platelet_physiology | 2.16496332 |
| 18 | MP0005387_immune_system_phenotype | 2.14511289 |
| 19 | MP0001790_abnormal_immune_system | 2.14511289 |
| 20 | MP0000490_abnormal_crypts_of | 2.13912259 |
| 21 | MP0005025_abnormal_response_to | 2.13795063 |
| 22 | * MP0001819_abnormal_immune_cell | 2.13324121 |
| 23 | MP0002723_abnormal_immune_serum | 2.09312182 |
| 24 | MP0005000_abnormal_immune_tolerance | 2.05385810 |
| 25 | MP0000689_abnormal_spleen_morphology | 2.03893027 |
| 26 | MP0000716_abnormal_immune_system | 1.99654299 |
| 27 | MP0003300_gastrointestinal_ulcer | 1.99142753 |
| 28 | MP0002166_altered_tumor_susceptibility | 1.97603796 |
| 29 | MP0003111_abnormal_nucleus_morphology | 1.97564440 |
| 30 | MP0002722_abnormal_immune_system | 1.96166029 |
| 31 | MP0003303_peritoneal_inflammation | 1.91675155 |
| 32 | * MP0002419_abnormal_innate_immunity | 1.90477440 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.86279133 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.86002203 |
| 35 | * MP0002429_abnormal_blood_cell | 1.84363938 |
| 36 | MP0010094_abnormal_chromosome_stability | 1.83860705 |
| 37 | MP0008260_abnormal_autophagy | 1.78147893 |
| 38 | MP0009278_abnormal_bone_marrow | 1.75774447 |
| 39 | MP0003077_abnormal_cell_cycle | 1.75060544 |
| 40 | * MP0005174_abnormal_tail_pigmentation | 1.74621333 |
| 41 | MP0000703_abnormal_thymus_morphology | 1.74317745 |
| 42 | MP0010155_abnormal_intestine_physiology | 1.73694877 |
| 43 | MP0006054_spinal_hemorrhage | 1.72901551 |
| 44 | MP0002405_respiratory_system_inflammati | 1.72174101 |
| 45 | MP0005451_abnormal_body_composition | 1.69915926 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.66889057 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.62779568 |
| 48 | MP0002148_abnormal_hypersensitivity_rea | 1.62523307 |
| 49 | * MP0003172_abnormal_lysosome_physiology | 1.61754037 |
| 50 | MP0008007_abnormal_cellular_replicative | 1.59960208 |
| 51 | MP0000858_altered_metastatic_potential | 1.57645340 |
| 52 | MP0001853_heart_inflammation | 1.54378422 |
| 53 | MP0003866_abnormal_defecation | 1.47601982 |
| 54 | MP0009764_decreased_sensitivity_to | 1.47065584 |
| 55 | MP0002006_tumorigenesis | 1.46950833 |
| 56 | MP0004957_abnormal_blastocyst_morpholog | 1.46210250 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.45602765 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.42369289 |
| 59 | MP0008004_abnormal_stomach_pH | 1.41208912 |
| 60 | MP0003075_altered_response_to | 1.40029506 |
| 61 | MP0002019_abnormal_tumor_incidence | 1.38180703 |
| 62 | MP0010307_abnormal_tumor_latency | 1.38149538 |
| 63 | * MP0005075_abnormal_melanosome_morpholog | 1.37669597 |
| 64 | MP0001845_abnormal_inflammatory_respons | 1.37457039 |
| 65 | MP0000569_abnormal_digit_pigmentation | 1.36631154 |
| 66 | MP0004947_skin_inflammation | 1.33050938 |
| 67 | MP0008057_abnormal_DNA_replication | 1.32967601 |
| 68 | MP0002998_abnormal_bone_remodeling | 1.32068609 |
| 69 | MP0002138_abnormal_hepatobiliary_system | 1.26216057 |
| 70 | MP0002132_abnormal_respiratory_system | 1.24979990 |
| 71 | MP0005083_abnormal_biliary_tract | 1.21302303 |
| 72 | MP0009840_abnormal_foam_cell | 1.18750137 |
| 73 | MP0004147_increased_porphyrin_level | 1.15664742 |
| 74 | MP0000604_amyloidosis | 1.15159572 |
| 75 | MP0002933_joint_inflammation | 1.14105512 |
| 76 | MP0003828_pulmonary_edema | 1.14081005 |
| 77 | MP0003724_increased_susceptibility_to | 1.13520651 |
| 78 | MP0008058_abnormal_DNA_repair | 1.11941491 |
| 79 | MP0006082_CNS_inflammation | 1.10952069 |
| 80 | MP0003191_abnormal_cellular_cholesterol | 1.10842618 |
| 81 | MP0001533_abnormal_skeleton_physiology | 1.09119220 |
| 82 | MP0000350_abnormal_cell_proliferation | 1.05423723 |
| 83 | MP0002877_abnormal_melanocyte_morpholog | 1.04422242 |
| 84 | MP0005166_decreased_susceptibility_to | 1.03712956 |
| 85 | MP0005023_abnormal_wound_healing | 1.03391498 |
| 86 | MP0002139_abnormal_hepatobiliary_system | 1.02231414 |
| 87 | * MP0008469_abnormal_protein_level | 1.00902019 |
| 88 | MP0000313_abnormal_cell_death | 1.00799104 |
| 89 | MP0002254_reproductive_system_inflammat | 0.97785786 |
| 90 | MP0005076_abnormal_cell_differentiation | 0.97749861 |
| 91 | MP0003566_abnormal_cell_adhesion | 0.95591424 |
| 92 | MP0000477_abnormal_intestine_morphology | 0.95146595 |
| 93 | * MP0002095_abnormal_skin_pigmentation | 0.92715416 |
| 94 | * MP0000371_diluted_coat_color | 0.92406064 |
| 95 | MP0005390_skeleton_phenotype | 0.90025203 |
| 96 | MP0005310_abnormal_salivary_gland | 0.87003943 |
| 97 | MP0003448_altered_tumor_morphology | 0.86466904 |
| 98 | MP0001849_ear_inflammation | 0.84738259 |
| 99 | MP0001663_abnormal_digestive_system | 0.83638923 |
| 100 | MP0003795_abnormal_bone_structure | 0.81929858 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.80786854 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 0.80526942 |
| 103 | MP0004381_abnormal_hair_follicle | 0.80083362 |
| 104 | MP0005164_abnormal_response_to | 0.78790718 |
| 105 | MP0001730_embryonic_growth_arrest | 0.76008439 |
| 106 | MP0000343_altered_response_to | 0.73974143 |
| 107 | MP0004883_abnormal_blood_vessel | 0.73622421 |
| 108 | MP0009765_abnormal_xenobiotic_induced | 0.72328566 |
| 109 | MP0008961_abnormal_basal_metabolism | 0.71642665 |
| 110 | MP0003279_aneurysm | 0.71174552 |
| 111 | MP0000358_abnormal_cell_content/ | 0.70628465 |
| 112 | MP0002080_prenatal_lethality | 0.69606149 |
| 113 | MP0003186_abnormal_redox_activity | 0.69027337 |
| 114 | MP0000609_abnormal_liver_physiology | 0.68439714 |
| 115 | MP0000598_abnormal_liver_morphology | 0.68283492 |
| 116 | MP0005621_abnormal_cell_physiology | 0.68023037 |
| 117 | MP0004510_myositis | 0.67768835 |
| 118 | MP0001542_abnormal_bone_strength | 0.66781345 |
| 119 | MP0003690_abnormal_glial_cell | 0.66649759 |
| 120 | MP0008874_decreased_physiological_sensi | 0.66376736 |
| 121 | MP0005365_abnormal_bile_salt | 0.65833478 |
| 122 | * MP0002075_abnormal_coat/hair_pigmentati | 0.64701270 |
| 123 | * MP0000249_abnormal_blood_vessel | 0.64663807 |
| 124 | MP0009763_increased_sensitivity_to | 0.63280900 |
| 125 | MP0003943_abnormal_hepatobiliary_system | 0.62670270 |
| 126 | * MP0005319_abnormal_enzyme/_coenzyme | 0.62506775 |
| 127 | MP0001348_abnormal_lacrimal_gland | 0.60393656 |
| 128 | MP0003045_fibrosis | 0.59714145 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.59697431 |
| 130 | MP0005165_increased_susceptibility_to | 0.59277056 |
| 131 | MP0005384_cellular_phenotype | 0.59028852 |
| 132 | MP0001915_intracranial_hemorrhage | 0.58938276 |
| 133 | MP0005220_abnormal_exocrine_pancreas | 0.58903862 |
| 134 | MP0001851_eye_inflammation | 0.57400227 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thrombocytosis (HP:0001894) | 5.09146145 |
| 2 | Abnormality of glycolipid metabolism (HP:0010969) | 4.39644602 |
| 3 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.39644602 |
| 4 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.39644602 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.12196288 |
| 6 | Chronic otitis media (HP:0000389) | 4.03119228 |
| 7 | IgM deficiency (HP:0002850) | 3.97073823 |
| 8 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 3.78069649 |
| 9 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.64679583 |
| 10 | Increased cerebral lipofuscin (HP:0011813) | 3.56983735 |
| 11 | Abnormal number of erythroid precursors (HP:0012131) | 3.56057035 |
| 12 | Aplastic anemia (HP:0001915) | 3.52526035 |
| 13 | Myositis (HP:0100614) | 3.41851101 |
| 14 | Recurrent bronchitis (HP:0002837) | 3.31490011 |
| 15 | Recurrent abscess formation (HP:0002722) | 3.29878726 |
| 16 | Reticulocytopenia (HP:0001896) | 3.28088511 |
| 17 | Purpura (HP:0000979) | 3.23910642 |
| 18 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.22997299 |
| 19 | Eczematoid dermatitis (HP:0000976) | 3.18656499 |
| 20 | Petechiae (HP:0000967) | 3.17775570 |
| 21 | Spontaneous hematomas (HP:0007420) | 3.13506740 |
| 22 | Systemic lupus erythematosus (HP:0002725) | 3.10493934 |
| 23 | Recurrent viral infections (HP:0004429) | 3.01729345 |
| 24 | Abnormality of T cell physiology (HP:0011840) | 2.94981667 |
| 25 | Cellulitis (HP:0100658) | 2.94610846 |
| 26 | Recurrent fungal infections (HP:0002841) | 2.91857372 |
| 27 | Hypochromic microcytic anemia (HP:0004840) | 2.90854030 |
| 28 | Recurrent bacterial skin infections (HP:0005406) | 2.89579131 |
| 29 | Impaired platelet aggregation (HP:0003540) | 2.89502219 |
| 30 | Abnormal platelet function (HP:0011869) | 2.89502219 |
| 31 | Loss of speech (HP:0002371) | 2.86844722 |
| 32 | Gastrointestinal infarctions (HP:0005244) | 2.86233421 |
| 33 | Optic neuritis (HP:0100653) | 2.85792059 |
| 34 | Retrobulbar optic neuritis (HP:0100654) | 2.85792059 |
| 35 | Nasal polyposis (HP:0100582) | 2.83270195 |
| 36 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.81237539 |
| 37 | Increased serum ferritin (HP:0003281) | 2.77820847 |
| 38 | Panhypogammaglobulinemia (HP:0003139) | 2.73633991 |
| 39 | Urticaria (HP:0001025) | 2.72027777 |
| 40 | Periodontitis (HP:0000704) | 2.70605041 |
| 41 | Hepatosplenomegaly (HP:0001433) | 2.67188468 |
| 42 | Encephalitis (HP:0002383) | 2.65735481 |
| 43 | Microcytic anemia (HP:0001935) | 2.65156076 |
| 44 | Pulmonary infiltrates (HP:0002113) | 2.62679151 |
| 45 | * Prolonged bleeding time (HP:0003010) | 2.62569334 |
| 46 | Abnormality of iron homeostasis (HP:0011031) | 2.61718009 |
| 47 | Meningitis (HP:0001287) | 2.60697395 |
| 48 | Hypochromic anemia (HP:0001931) | 2.54709548 |
| 49 | * Epistaxis (HP:0000421) | 2.54662895 |
| 50 | Pallor (HP:0000980) | 2.54238718 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.53581727 |
| 52 | Abnormality of T cells (HP:0002843) | 2.53050286 |
| 53 | Polycythemia (HP:0001901) | 2.51918082 |
| 54 | Gingivitis (HP:0000230) | 2.49927608 |
| 55 | Lymphopenia (HP:0001888) | 2.48945911 |
| 56 | Abnormality of macrophages (HP:0004311) | 2.48845836 |
| 57 | Increased IgM level (HP:0003496) | 2.48764724 |
| 58 | Mediastinal lymphadenopathy (HP:0100721) | 2.48661731 |
| 59 | * Gastrointestinal inflammation (HP:0004386) | 2.48466282 |
| 60 | Thoracic kyphosis (HP:0002942) | 2.47869620 |
| 61 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.46290879 |
| 62 | Pustule (HP:0200039) | 2.45067199 |
| 63 | Hyperacusis (HP:0010780) | 2.42153976 |
| 64 | Abnormality of the thoracic spine (HP:0100711) | 2.40956590 |
| 65 | Colitis (HP:0002583) | 2.40254326 |
| 66 | Chest pain (HP:0100749) | 2.38700852 |
| 67 | Progressive neurologic deterioration (HP:0002344) | 2.35372521 |
| 68 | * Gingival bleeding (HP:0000225) | 2.34908173 |
| 69 | Hemoptysis (HP:0002105) | 2.32912018 |
| 70 | Abnormality of the fingertips (HP:0001211) | 2.32484998 |
| 71 | * Inflammation of the large intestine (HP:0002037) | 2.32043067 |
| 72 | Type I transferrin isoform profile (HP:0003642) | 2.31562077 |
| 73 | Amaurosis fugax (HP:0100576) | 2.31286558 |
| 74 | Interstitial pulmonary disease (HP:0006530) | 2.30221284 |
| 75 | Lymphoma (HP:0002665) | 2.27659610 |
| 76 | Poikiloderma (HP:0001029) | 2.27614734 |
| 77 | Hypertensive crisis (HP:0100735) | 2.25757467 |
| 78 | Stomatitis (HP:0010280) | 2.25030271 |
| 79 | Recurrent skin infections (HP:0001581) | 2.24131130 |
| 80 | Abnormality of B cell number (HP:0010975) | 2.23295347 |
| 81 | B lymphocytopenia (HP:0010976) | 2.23295347 |
| 82 | Episodic fever (HP:0001954) | 2.22750874 |
| 83 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.18732598 |
| 84 | Agammaglobulinemia (HP:0004432) | 2.18564652 |
| 85 | Vacuolated lymphocytes (HP:0001922) | 2.16066813 |
| 86 | Abnormal protein glycosylation (HP:0012346) | 2.14448283 |
| 87 | Abnormal glycosylation (HP:0012345) | 2.14448283 |
| 88 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.14448283 |
| 89 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.14448283 |
| 90 | Granulocytopenia (HP:0001913) | 2.14358995 |
| 91 | Vasculitis (HP:0002633) | 2.14075177 |
| 92 | Hypergammaglobulinemia (HP:0010702) | 2.13908112 |
| 93 | Keratoconjunctivitis sicca (HP:0001097) | 2.13855984 |
| 94 | Obstructive lung disease (HP:0006536) | 2.13095789 |
| 95 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13095789 |
| 96 | Reduced antithrombin III activity (HP:0001976) | 2.11630235 |
| 97 | Spondylolisthesis (HP:0003302) | 2.10005042 |
| 98 | Fatigue (HP:0012378) | 2.06831787 |
| 99 | Osteomyelitis (HP:0002754) | 2.06249797 |
| 100 | Autoimmune hemolytic anemia (HP:0001890) | 2.05985216 |
| 101 | Anorexia (HP:0002039) | 2.05325163 |
| 102 | Leukocytosis (HP:0001974) | 2.05257577 |
| 103 | Myelodysplasia (HP:0002863) | 2.04912862 |
| 104 | Increased IgE level (HP:0003212) | 2.04302440 |
| 105 | Increased density of long bones (HP:0006392) | 2.04252991 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.04221766 |
| 107 | Arterial thrombosis (HP:0004420) | 2.03989312 |
| 108 | Chronic sinusitis (HP:0011109) | 2.03960177 |
| 109 | Emphysema (HP:0002097) | 2.03813362 |
| 110 | Basal cell carcinoma (HP:0002671) | 2.03512833 |
| 111 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.03393540 |
| 112 | Mucopolysacchariduria (HP:0008155) | 2.03393540 |
| 113 | Broad face (HP:0000283) | 2.00521821 |
| 114 | T lymphocytopenia (HP:0005403) | 2.00473011 |
| 115 | Recurrent cutaneous fungal infections (HP:0011370) | 1.99239067 |
| 116 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.99239067 |
| 117 | Amyloidosis (HP:0011034) | 1.98546768 |
| 118 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.98308686 |
| 119 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.98308686 |
| 120 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.98308686 |
| 121 | Dysostosis multiplex (HP:0000943) | 1.98099481 |
| 122 | Acute lymphatic leukemia (HP:0006721) | 1.97817550 |
| 123 | Abnormality of T cell number (HP:0011839) | 1.97791089 |
| 124 | Gastrointestinal stroma tumor (HP:0100723) | 1.97267703 |
| 125 | Acute myeloid leukemia (HP:0004808) | 1.96895181 |
| 126 | Pulmonary embolism (HP:0002204) | 1.96531734 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.96267682 |
| 128 | Keratoconjunctivitis (HP:0001096) | 1.93072134 |
| 129 | Splenomegaly (HP:0001744) | 1.92441286 |
| 130 | Skin ulcer (HP:0200042) | 1.89799978 |
| 131 | Orchitis (HP:0100796) | 1.89314036 |
| 132 | Skin rash (HP:0000988) | 1.89211023 |
| 133 | Autoimmune thrombocytopenia (HP:0001973) | 1.87436959 |
| 134 | Abnormal hemoglobin (HP:0011902) | 1.87119327 |
| 135 | Arthralgia (HP:0002829) | 1.86939388 |
| 136 | Myocardial infarction (HP:0001658) | 1.84986962 |
| 137 | Recurrent lower respiratory tract infections (HP:0002783) | 1.84858934 |
| 138 | Microretrognathia (HP:0000308) | 1.84345442 |
| 139 | Abnormality of the prostate (HP:0008775) | 1.83617623 |
| 140 | Radial bowing (HP:0002986) | 1.82362055 |
| 141 | Macrocytic anemia (HP:0001972) | 1.81911853 |
| 142 | IgA deficiency (HP:0002720) | 1.79197036 |
| 143 | Eosinophilia (HP:0001880) | 1.77803793 |
| 144 | Abnormality of the anterior horn cell (HP:0006802) | 1.77435858 |
| 145 | Degeneration of anterior horn cells (HP:0002398) | 1.77435858 |
| 146 | Leukopenia (HP:0001882) | 1.76528338 |
| 147 | Abnormal platelet volume (HP:0011876) | 1.74743359 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.18805009 |
| 2 | EEF2K | 3.19410002 |
| 3 | KIT | 2.71375251 |
| 4 | PRPF4B | 2.64061956 |
| 5 | ERN1 | 2.49004255 |
| 6 | SCYL2 | 2.30039083 |
| 7 | FLT3 | 2.29120265 |
| 8 | MAP3K3 | 2.25509173 |
| 9 | ZAP70 | 2.21990419 |
| 10 | TRIB3 | 2.19843662 |
| 11 | BTK | 2.15065912 |
| 12 | TAOK2 | 2.07902877 |
| 13 | PKN2 | 2.03110883 |
| 14 | JAK3 | 1.97965249 |
| 15 | TAOK1 | 1.96849439 |
| 16 | NME2 | 1.89520476 |
| 17 | BLK | 1.87385463 |
| 18 | MAP3K10 | 1.82535339 |
| 19 | TYK2 | 1.81214306 |
| 20 | LRRK2 | 1.69018551 |
| 21 | CSF1R | 1.68719848 |
| 22 | TBK1 | 1.59737944 |
| 23 | IRAK4 | 1.59328931 |
| 24 | NEK2 | 1.58178361 |
| 25 | MAP2K3 | 1.55618615 |
| 26 | TEC | 1.52941188 |
| 27 | TESK2 | 1.45867149 |
| 28 | STK10 | 1.45566215 |
| 29 | GRK6 | 1.42758629 |
| 30 | WEE1 | 1.40092116 |
| 31 | MAP3K1 | 1.39109222 |
| 32 | RPS6KA4 | 1.36812543 |
| 33 | SYK | 1.34191801 |
| 34 | PAK4 | 1.33159925 |
| 35 | MAPKAPK3 | 1.33003937 |
| 36 | FGR | 1.32321109 |
| 37 | RPS6KB2 | 1.32271589 |
| 38 | TGFBR1 | 1.29478988 |
| 39 | TAOK3 | 1.28897720 |
| 40 | TXK | 1.28145185 |
| 41 | BUB1 | 1.26668755 |
| 42 | EIF2AK3 | 1.25230753 |
| 43 | CDC7 | 1.24468830 |
| 44 | IRAK3 | 1.21827326 |
| 45 | CDK12 | 1.20138268 |
| 46 | PASK | 1.18294645 |
| 47 | SIK2 | 1.17132035 |
| 48 | PIM2 | 1.12445478 |
| 49 | KDR | 1.11374919 |
| 50 | IKBKE | 1.09065146 |
| 51 | LCK | 1.08555265 |
| 52 | PRKD2 | 1.07860061 |
| 53 | IKBKB | 1.04746585 |
| 54 | HCK | 1.04590404 |
| 55 | CDK7 | 1.04496413 |
| 56 | CDC42BPA | 1.01854058 |
| 57 | EIF2AK1 | 1.00475236 |
| 58 | CDK4 | 0.99050119 |
| 59 | PIM1 | 0.98460053 |
| 60 | TGFBR2 | 0.97062647 |
| 61 | MAP3K11 | 0.95243639 |
| 62 | PTK6 | 0.93639150 |
| 63 | VRK1 | 0.92308013 |
| 64 | ITK | 0.92210233 |
| 65 | SMG1 | 0.90953837 |
| 66 | ATR | 0.90440543 |
| 67 | BMX | 0.90229717 |
| 68 | BMPR2 | 0.90056938 |
| 69 | LYN | 0.87721849 |
| 70 | ACVR1B | 0.87100752 |
| 71 | ARAF | 0.86343751 |
| 72 | RIPK1 | 0.85368272 |
| 73 | MATK | 0.83666625 |
| 74 | MAP3K8 | 0.83567027 |
| 75 | TESK1 | 0.83541001 |
| 76 | FES | 0.81188111 |
| 77 | JAK1 | 0.80255620 |
| 78 | MAP3K13 | 0.77721429 |
| 79 | DYRK3 | 0.77349061 |
| 80 | MAP3K14 | 0.75000389 |
| 81 | FGFR4 | 0.72477537 |
| 82 | SIK1 | 0.72343064 |
| 83 | PDPK1 | 0.70587343 |
| 84 | GRK7 | 0.68508600 |
| 85 | DAPK1 | 0.68488421 |
| 86 | CDK8 | 0.67430211 |
| 87 | HIPK2 | 0.67296171 |
| 88 | CDK6 | 0.65503302 |
| 89 | STK16 | 0.64800025 |
| 90 | PDK1 | 0.64193138 |
| 91 | CLK1 | 0.62306519 |
| 92 | CHUK | 0.62145255 |
| 93 | BRD4 | 0.61841156 |
| 94 | PTK2B | 0.61507849 |
| 95 | MARK2 | 0.61356023 |
| 96 | SIK3 | 0.60253396 |
| 97 | RPS6KL1 | 0.59975319 |
| 98 | RPS6KC1 | 0.59975319 |
| 99 | MAPK7 | 0.59956482 |
| 100 | CSK | 0.59711312 |
| 101 | KSR2 | 0.59254632 |
| 102 | ABL2 | 0.58336427 |
| 103 | MAPK12 | 0.56272632 |
| 104 | MAP2K6 | 0.56153882 |
| 105 | FGFR3 | 0.54480823 |
| 106 | JAK2 | 0.53572388 |
| 107 | AURKB | 0.52505544 |
| 108 | MAP3K5 | 0.51460040 |
| 109 | PRKG2 | 0.51454933 |
| 110 | PRKCQ | 0.50579465 |
| 111 | MAP3K7 | 0.50487216 |
| 112 | RPS6KA6 | 0.47047248 |
| 113 | RIPK4 | 0.47013623 |
| 114 | TTN | 0.46904039 |
| 115 | BCKDK | 0.45919057 |
| 116 | RPS6KA2 | 0.44191453 |
| 117 | STK4 | 0.44106879 |
| 118 | ALK | 0.44003890 |
| 119 | MAPK11 | 0.43944186 |
| 120 | FYN | 0.43877151 |
| 121 | MAP3K6 | 0.43743470 |
| 122 | DDR2 | 0.41543859 |
| 123 | IRAK1 | 0.39986176 |
| 124 | CDK19 | 0.39765388 |
| 125 | IRAK2 | 0.39202318 |
| 126 | RAF1 | 0.39083418 |
| 127 | MAP3K12 | 0.39076333 |
| 128 | MAP2K2 | 0.38569715 |
| 129 | EPHB1 | 0.38286735 |
| 130 | BRSK2 | 0.37792207 |
| 131 | TNK2 | 0.37654514 |
| 132 | MAPKAPK2 | 0.35853754 |
| 133 | NLK | 0.35027313 |
| 134 | MTOR | 0.34339563 |
| 135 | MARK3 | 0.33886441 |
| 136 | DAPK2 | 0.32712292 |
| 137 | CAMKK2 | 0.30801697 |
| 138 | PRKD1 | 0.30566064 |
| 139 | MAPK4 | 0.29735544 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 3.78675411 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 2.99623661 |
| 3 | Allograft rejection_Homo sapiens_hsa05330 | 2.86428970 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.79571820 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.72408459 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.64776192 |
| 7 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.63863877 |
| 8 | Base excision repair_Homo sapiens_hsa03410 | 2.36477378 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.12468028 |
| 10 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.08658795 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 1.95528543 |
| 12 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.92010176 |
| 13 | Spliceosome_Homo sapiens_hsa03040 | 1.89045218 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86742389 |
| 15 | Other glycan degradation_Homo sapiens_hsa00511 | 1.78577366 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.75292728 |
| 17 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.73026147 |
| 18 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.72527238 |
| 19 | Measles_Homo sapiens_hsa05162 | 1.66963827 |
| 20 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.64340252 |
| 21 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.54717672 |
| 22 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.53318866 |
| 23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.53058205 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.50939152 |
| 25 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.50150037 |
| 26 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.50073241 |
| 27 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.49881738 |
| 28 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.46390029 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.45729602 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.35620315 |
| 31 | Phagosome_Homo sapiens_hsa04145 | 1.35222497 |
| 32 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.34206188 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.33988016 |
| 34 | Cell cycle_Homo sapiens_hsa04110 | 1.33302863 |
| 35 | Sulfur relay system_Homo sapiens_hsa04122 | 1.31329016 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.30625798 |
| 37 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.29950690 |
| 38 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.29798946 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.27665747 |
| 40 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.25523690 |
| 41 | Shigellosis_Homo sapiens_hsa05131 | 1.25341543 |
| 42 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.24225479 |
| 43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.23347047 |
| 44 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.23178589 |
| 45 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.21176463 |
| 46 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.19568484 |
| 47 | Apoptosis_Homo sapiens_hsa04210 | 1.18934693 |
| 48 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.16352060 |
| 49 | Legionellosis_Homo sapiens_hsa05134 | 1.16194365 |
| 50 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.13202015 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.12336248 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.08504987 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.07064410 |
| 54 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.05710059 |
| 55 | Hepatitis B_Homo sapiens_hsa05161 | 1.03896368 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.00427129 |
| 57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98272227 |
| 58 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.98025140 |
| 59 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.97934720 |
| 60 | HTLV-I infection_Homo sapiens_hsa05166 | 0.97910717 |
| 61 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97828621 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95640193 |
| 63 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.95384987 |
| 64 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.95099553 |
| 65 | Platelet activation_Homo sapiens_hsa04611 | 0.92302883 |
| 66 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.92223719 |
| 67 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.90679253 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.88122621 |
| 69 | RNA degradation_Homo sapiens_hsa03018 | 0.85919338 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85380292 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.85236636 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.83886941 |
| 73 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.82604082 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.80651606 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.79279429 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.78796569 |
| 77 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.74596831 |
| 78 | Malaria_Homo sapiens_hsa05144 | 0.74326357 |
| 79 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.74125925 |
| 80 | Thyroid cancer_Homo sapiens_hsa05216 | 0.74118378 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.72945911 |
| 82 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.71997809 |
| 83 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.71740246 |
| 84 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70699702 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69812751 |
| 86 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.68240580 |
| 87 | RNA polymerase_Homo sapiens_hsa03020 | 0.67627275 |
| 88 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67122184 |
| 89 | Endocytosis_Homo sapiens_hsa04144 | 0.65955346 |
| 90 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.64191038 |
| 91 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63088191 |
| 92 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.62677384 |
| 93 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.61885988 |
| 94 | Colorectal cancer_Homo sapiens_hsa05210 | 0.60950480 |
| 95 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.59640754 |
| 96 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.58081824 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.57898408 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57650180 |
| 99 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.57528275 |
| 100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.57437806 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57141547 |
| 102 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.56738870 |
| 103 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.54783234 |
| 104 | Asthma_Homo sapiens_hsa05310 | 0.54618327 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53455808 |
| 106 | Salmonella infection_Homo sapiens_hsa05132 | 0.53248907 |
| 107 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.52893708 |
| 108 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52447475 |
| 109 | Proteasome_Homo sapiens_hsa03050 | 0.51461592 |
| 110 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49771188 |
| 111 | Lysine degradation_Homo sapiens_hsa00310 | 0.49275223 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.47674490 |
| 113 | Bladder cancer_Homo sapiens_hsa05219 | 0.47214136 |
| 114 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47127921 |
| 115 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.46179715 |
| 116 | Hepatitis C_Homo sapiens_hsa05160 | 0.45642438 |
| 117 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.44605682 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43322644 |
| 119 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42717138 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.42124749 |
| 121 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.41539747 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.41386306 |
| 123 | Prion diseases_Homo sapiens_hsa05020 | 0.39330160 |
| 124 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.39199525 |
| 125 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.36223314 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33193255 |
| 127 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.31702343 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.30115179 |
| 129 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.29333952 |
| 130 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.29149727 |
| 131 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.28518984 |
| 132 | Insulin resistance_Homo sapiens_hsa04931 | 0.27579731 |
| 133 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27255747 |
| 134 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.25592961 |
| 135 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.24601365 |

